Dr Kevin L Lenahan, DC | |
9003 Havensight Mall, 308, St.thomas, VI 00802 | |
(340) 774-4346 | |
(340) 774-4346 |
Full Name | Dr Kevin L Lenahan |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 9003 Havensight Mall, St.thomas, Virgin Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427186733 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | 11C (Virgin Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kevin L Lenahan, DC 9003 Havensight Mall, 308, St.thomas, VI 00802 Ph: (340) 774-4346 | Dr Kevin L Lenahan, DC 9003 Havensight Mall, 308, St.thomas, VI 00802 Ph: (340) 774-4346 |
News Archive
A new study has shown that choosing to eat healthy can be expensive. Researchers from the University of Washington looked at the economic impact of following new U.S. dietary guidelines, which recommend eating more potassium, dietary fiber, vitamin D and calcium, and avoiding saturated fat and added sugar. These recommendations aimed at curbing the rising number of obese and overweight individuals, but the study findings underline some of the obstacles to adopting new habits.
Women comprise more than half the population of the nation's cities, are three times as likely as their male counterparts to live alone after the age of 65, and are primary caregivers for their families at all ages and stages of life. The University of Pennsylvania School of Nursing, with the International Congress of Women's Health Issues, will host "Cities and Women's Health: Global Perspectives," Wednesday, April 7, through Saturday, April 10, on Penn's campus to examine how urban environments affect their health.
KHN reports: "Over the weekend, Senate Finance Committee Chairman Max Baucus, D-Mont., proposed a health care overhaul "framework" for committee consideration that would cost under $900 billion over the next decade, according to a source close to the negotiations.
A new study suggests that Oncotype DX-guided treatment could reduce the cost for the first year of breast cancer care in the U.S. by about $50 million (about 2 percent of the overall costs in the first year).
› Verified 1 days ago